Flu vaccine-based therapy for TIIDM and obesity-associated metabolic deficits: Influenza A (H1N1)/Flu vaccine increases Lipocalin 2 (LCN2) expression, activates an MC4R-dependent anorexigenic pathway, suppresses appetite and weight gain, increases insulin secretion, improves glucose tolerance, promotes glucose homeostasis, improves obesity-associated metabolic deficits and prevents progression to TIIDM via down-regulation of its target gene, 23/July/2018, 11.01 am